Application | Comment | Organism |
---|---|---|
medicine | putative development of a screening of MBL producing strains by routine clinical microbiology laboratories. The detection of the MBL phenotype of resistance is of crucial importance for selecting the most appropriate therapy and applying infection control measures | Enterobacter cloacae |
medicine | putative development of a screening of MBL producing strains by routine clinical microbiology laboratories. The detection of the MBL phenotype of resistance is of crucial importance for selecting the most appropriate therapy and applying infection control measures | Pseudomonas aeruginosa |
medicine | putative development of a screening of MBL producing strains by routine clinical microbiology laboratories. The detection of the MBL phenotype of resistance is of crucial importance for selecting the most appropriate therapy and applying infection control measures | Serratia marcescens |
medicine | putative development of a screening of MBL producing strains by routine clinical microbiology laboratories. The detection of the MBL phenotype of resistance is of crucial importance for selecting the most appropriate therapy and applying infection control measures | Klebsiella pneumoniae |
medicine | putative development of a screening of MBL producing strains by routine clinical microbiology laboratories. The detection of the MBL phenotype of resistance is of crucial importance for selecting the most appropriate therapy and applying infection control measures. | Pseudomonas putida |
medicine | putative development of a screening of MBL producing strains by routine clinical microbiology laborities. The detection of the MBL phenotype of resistance is of crucial importance for selecting the most appropriate therapy and applying infection control measures | Acinetobacter sp. |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-mercaptoethanol | mercaptoethanol shows no growth inhibition activity on Pseudomonas aeruginosa ATCC 27583 at all tested concentrations between 7.0 and 55 mM | Pseudomonas aeruginosa | |
EDTA | EDTA, PHEN, and MET present weak bactericidal activity against Pseudomonas aeruginosa with substrate ceftazidime | Pseudomonas aeruginosa | |
Mercaptoacetic acid | mercaptoacetic acid demonstrates hydrolytic activity against imipenem but not against ceftazidime | Pseudomonas aeruginosa | |
Mercaptopropionic acid | 1.4 mM mercaptopropionic acid demonstrates hydrolytic activity against imipenem but not against ceftazidime, mercaptopropionic acid provided the best results by using imipenem as substrate | Acinetobacter sp. | |
Mercaptopropionic acid | 1.4 mM mercaptopropionic acid demonstrates hydrolytic activity against imipenem but not against ceftazidime, mercaptopropionic acid provided the best results by using imipenem as substrate | Pseudomonas aeruginosa | |
additional information | the bactericidal effect of inhibitors of MBL is not influenced by the production of the MBL variants IMP, VIM, SPM, GIM, or SIM | Pseudomonas aeruginosa | |
Phenanthroline | phenanthroline shows no growth inhibition activity on Pseudomonas aeruginosa ATCC 27583 at all tested concentrations between 1.0 and 8.0 mM | Pseudomonas aeruginosa |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
a beta-lactam + H2O | Enterobacter cloacae | - |
a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | Pseudomonas aeruginosa | - |
a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | Pseudomonas putida | - |
a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | Serratia marcescens | - |
a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | Klebsiella pneumoniae | - |
a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | Acinetobacter sp. | - |
a substituted beta-amino acid | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Acinetobacter sp. | - |
IMP-1 producing strains A3035, A4861, A3880, A68, A4764, A4468, A129046, A695 and A696, and SIM-1 producing strain YMC 03/9/T104 | - |
Enterobacter cloacae | - |
VIM-1 producing strains 75-10344, ECL3 and ECL4, and IMP-1 producing strain 199 | - |
Klebsiella pneumoniae | - |
IMP-1 producing strains KPN1 and KPN2 | - |
Pseudomonas aeruginosa | - |
strain ATCC 27853, IMP-1 producing strains 131, 144, 137, 98, 128, 130, 143, 145, 183, PSA320, IMP-13 producing strain 86-10079, IMP-16 producing strain 101-4704, IMP-18 producing strains 3486 and 3489, GIM-1 producing strain 73-5671, VIM-1 producing strain 179, VIM-2 producing strain 225 and VIM-7 producing strain 07-406, SPM-1 producing strains 48-1997 A, 14, 44, 73, 75, 76, 83, 194, 196 and 197 | - |
Pseudomonas putida | - |
IMP-1 producing strain 48-12346A | - |
Serratia marcescens | - |
IMP-1 producing strain SM319 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cell culture | - |
Enterobacter cloacae | - |
cell culture | - |
Pseudomonas aeruginosa | - |
cell culture | - |
Pseudomonas putida | - |
cell culture | - |
Serratia marcescens | - |
cell culture | - |
Klebsiella pneumoniae | - |
cell culture | - |
Acinetobacter sp. | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
a beta-lactam + H2O | - |
Enterobacter cloacae | a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | - |
Pseudomonas aeruginosa | a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | - |
Pseudomonas putida | a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | - |
Serratia marcescens | a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | - |
Klebsiella pneumoniae | a substituted beta-amino acid | - |
? | |
a beta-lactam + H2O | - |
Acinetobacter sp. | a substituted beta-amino acid | - |
? | |
ceftazidime + H2O | cephalosporin antibiotic | Enterobacter cloacae | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
ceftazidime + H2O | cephalosporin antibiotic | Pseudomonas aeruginosa | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
ceftazidime + H2O | cephalosporin antibiotic | Pseudomonas putida | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
ceftazidime + H2O | cephalosporin antibiotic | Serratia marcescens | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
ceftazidime + H2O | cephalosporin antibiotic | Klebsiella pneumoniae | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
ceftazidime + H2O | cephalosporin antibiotic | Acinetobacter sp. | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-[(pyridin-1-ium-1-yl)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylate | - |
? | |
imipenem + H2O | beta-lactam antibiotic | Enterobacter cloacae | (5R)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? | |
imipenem + H2O | beta-lactam antibiotic | Pseudomonas aeruginosa | (5R)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? | |
imipenem + H2O | beta-lactam antibiotic | Pseudomonas putida | (5R)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? | |
imipenem + H2O | beta-lactam antibiotic | Serratia marcescens | (5R)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? | |
imipenem + H2O | beta-lactam antibiotic | Klebsiella pneumoniae | (5R)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? | |
imipenem + H2O | beta-lactam antibiotic | Acinetobacter sp. | (5R)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | - |
? |
Synonyms | Comment | Organism |
---|---|---|
GIM-1 | - |
Pseudomonas aeruginosa |
IMP-1 | - |
Enterobacter cloacae |
IMP-1 | - |
Pseudomonas aeruginosa |
IMP-1 | - |
Pseudomonas putida |
IMP-1 | - |
Serratia marcescens |
IMP-1 | - |
Klebsiella pneumoniae |
IMP-1 | - |
Acinetobacter sp. |
IMP-13 | - |
Pseudomonas aeruginosa |
IMP-16 | - |
Pseudomonas aeruginosa |
IMP-18 | - |
Pseudomonas aeruginosa |
MBL | - |
Enterobacter cloacae |
MBL | - |
Pseudomonas aeruginosa |
MBL | - |
Pseudomonas putida |
MBL | - |
Serratia marcescens |
MBL | - |
Klebsiella pneumoniae |
MBL | - |
Acinetobacter sp. |
metallo-beta-lactamase | - |
Enterobacter cloacae |
metallo-beta-lactamase | - |
Pseudomonas aeruginosa |
metallo-beta-lactamase | - |
Pseudomonas putida |
metallo-beta-lactamase | - |
Serratia marcescens |
metallo-beta-lactamase | - |
Klebsiella pneumoniae |
metallo-beta-lactamase | - |
Acinetobacter sp. |
SIM-1 | - |
Acinetobacter sp. |
SPM-1 | - |
Pseudomonas aeruginosa |
VIM-1 | - |
Enterobacter cloacae |
VIM-1 | - |
Pseudomonas aeruginosa |
VIM-2 | - |
Pseudomonas aeruginosa |
VIM-7 | - |
Pseudomonas aeruginosa |